caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1033197504

John DevineM.D.

PRACTICECENTER FOR UROGYNECOLOGY AND FEMALE PELVIC HEALTHSee all providers at this practice →
Obstetrics & GynecologyVenice, FLI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (3)

CCN 100087
Hospital
CCN 100166
Hospital
CCN 100359
Hospital
REFERRAL NETWORK

Where John Devine's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
SUMMA BARBERTON CITIZENS HOSPITAL2647
SUMMA HEALTH SYSTEM2345
SUMMA BARBERTON CITIZENS HOSPITAL1638
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
SUMMA BARBERTON CITIZENS HOSPITAL5690
JOHN B. DEVINE II M.D. INC.5681
SUMMA HEALTH SYSTEM3362
AKRON GENERAL MEDICAL CENTER2480
SUMMA BARBERTON CITIZENS HOSPITAL2168
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,223
Unique beneficiaries
—
Total services
2,142
Distinct HCPCS
10
Medicare payment
$180K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,387 Obstetrics & Gynecology providers in FL — top quintile (cohort median 134).
PRESCRIBING · PART D · 2024
Total Rx claims
1,340
Beneficiaries
—
Total drug cost
$137K
Distinct drugs
20
Brand share
39.9%
Top prescribed drugs
Estradiol544 claims
Nitrofurantoin Monohyd/M-Cryst172 claims
Progesterone, Micronized110 claims
Fluconazole87 claims
Vibegron56 claims
QUALITY · MIPS · 2024
Final MIPS score
80.8
Quality
65.0
Cost
65.3
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.24%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.